A carregar...
Cardiovascular safety of therapies for Type 2 diabetes
INTRODUCTION: Dipeptidyl peptidase-4 (DPP4) inhibitors, glucagon-like peptide-1 (GLP-1) analogs and sodium-glucose cotransporter 2 (SGLT2) inhibitors are relatively new therapies for the treatment of type 2 diabetes mellitus. Given the high prevalence of cardiovascular complications in patients with...
Na minha lista:
| Publicado no: | Expert Opin Drug Saf |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5523835/ https://ncbi.nlm.nih.gov/pubmed/27652617 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14740338.2017.1239707 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|